Leslie Douglas
-
- Cell death mechanisms and regulation 9
- RNA Interference and Gene Delivery 4
-
- Cancer-related Molecular Pathways 4
- Colorectal Cancer Treatments and Studies 2
-
- NF-κB Signaling Pathways 6
-
- Phagocytosis and Immune Regulation 1
-
- Healthcare Systems and Technology 2
-
- Autophagy in Disease and Therapy 1
- Co-authors
- Janet A. HoughtonKamel IzeradjeneDavid M. TillmanIstván PetákJohn L. ClevelandJennifer S. CarewSteffan T. NawrockiRobin Humphreys
- Partner nations
- United StatesHungaryItaly
In The Last Decade
Leslie Douglas
12 papers receiving 581 citations
Peers
Comparison fields: 5 of 76
- Molecular Biology 476
- Oncology 176
- Cancer Research 97
- Immunology 114
- Pathology and Forensic Medicine 42
Countries citing papers authored by Leslie Douglas
This map shows the geographic impact of Leslie Douglas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Douglas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Douglas more than expected).
Fields of papers citing papers by Leslie Douglas
This network shows the impact of papers produced by Leslie Douglas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Douglas. The network helps show where Leslie Douglas may publish in the future.
Co-authorship network
The 24 scholars most cited alongside Leslie Douglas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2015 | 4 | |
| 3 | 2007 | 52 | |
| 4 | 2006 | 31 | |
| 5 | 2005 | 73 | |
| 6 | 2005 | 91 | |
| 7 | 2004 | 20 | |
| 8 | 2004 | 50 | |
| 9 | 2004 | 40 | |
| 10 | 2003 | 28 | |
| 11 | Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C. | 2003 | 90 |
| 12 | Modulation of the Fas signaling pathway by IFN-gamma in therapy of colon cancer: phase I trial and correlative studies of IFN-gamma, 5-fluorouracil, and leucovorin. | 2002 | 27 |
| 13 | Pediatric rhabdomyosarcoma cell lines are resistant to Fas-induced apoptosis and highly sensitive to TRAIL-induced apoptosis. | 2000 | 83 |
About Leslie Douglas
Leslie Douglas is a scholar working on Issues, ethics and legal aspects, Cancer Research and Oncology, having authored 13 papers that have together received 589 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (9 papers), NF-κB Signaling Pathways (6 papers), RNA Interference and Gene Delivery (4 papers), Cancer-related Molecular Pathways (4 papers), Colorectal Cancer Treatments and Studies (2 papers), Healthcare Systems and Technology (2 papers), Autophagy in Disease and Therapy (1 paper) and Phagocytosis and Immune Regulation (1 paper). The work is most often cited by research in Molecular Biology (476 citations), Oncology (176 citations) and Cancer Research (97 citations). Leslie Douglas has collaborated with scholars based in United States, Hungary and Italy. Frequent co-authors include Janet A. Houghton, Kamel Izeradjene, David M. Tillman, István Peták, John L. Cleveland, Jennifer S. Carew, Steffan T. Nawrocki, Robin Humphreys, P. Kellie Turner and Lee S. Schwartzberg. Their work appears in journals such as Cancer Research, Oncogene and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.